ctrl K

AI Score

Unlock

Virax Biolabs Group Limit... (VRAX)

AI Score

Unlock

1.65

-0.06 (-3.51%)

At close: Feb 28, 2025, 3:59 PM

1.67

1.21%

After-hours: Feb 28, 2025, 04:00 PM EST

Virax Biolabs Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20
Revenue	156.42K	8.56K	n/a	123.82K	99.88K
Cost of Revenue	105.83K	9.93K	n/a	133.25K	54.13K
Gross Profit	50.59K	-1.36K	n/a	-9.43K	45.75K
Operating Income	-6.5M	-5.73M	-1.73M	-644.54K	-651.24K
Interest Income	n/a	15.47K	15.44K	28.64K	90.69K
Pretax Income	-6.74M	-5.46M	-1.75M	-672.91K	-739.46K
Net Income	-6.73M	-5.46M	-1.71M	-650.98K	-801.13K
Selling & General & Admin	4.59M	5.33M	1.3M	514.88K	609.99K
Research & Development	1.56M	397.11K	433.74K	120.22K	87K
Other Expenses	390.36K	290.47K	n/a	266.00	2.47K
Operating Expenses	6.55M	5.73M	1.73M	635.1K	696.99K
Interest Expense	26.88K	15.47K	15.44K	28.64K	90.69K
Selling & Marketing Expenses	n/a	26.62K	13.82K	57.2K	7.69K
Cost & Expenses	6.65M	5.74M	1.73M	768.36K	751.12K
Income Tax	n/a	-271	-1.77M	-666.47K	61.67K
Shares Outstanding (Basic)	2.01M	1.06M	1.14M	1.14M	1.14M
Shares Outstanding (Diluted)	2.01M	1.06M	1.14M	1.14M	1.14M
EPS (Basic)	-3.36	-5.13	-1.5	-0.57	-0.7
EPS (Diluted)	-3.36	-5.13	-1.5	-0.57	-0.7
EBITDA	-6.61M	-5.44M	-750	n/a	-648.77K
Depreciation & Amortization	103.1K	1.00	1.73M	644.54K	651.24K